Effectiveness of Yoga Comparing to Amantadine and Commitment Group Therapy in Patients with Multiple Sclerosis

Effectiveness of Yoga Comparing to Amantadine and Commitment Group Therapy on Fatigue and Pain and Life Quality in Patients with Multiple Sclerosis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200423047176N1

Enrollment

Registered

2020-04-29

Start date

2020-04-27

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MULTIPLE SCLEROSIS. Multiple sclerosis

Interventions

Intervention 1: Intervention Group 1 Yoga Exercises: For 12 weeks and three sessions each week and each session for 75-60 minutes under the supervision of an experienced instructor. Asana (movement) e

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Definitive diagnosis based on neurological examinations and MRI Symptoms of pain and fatigue that have been confirmed by interview and questionnaire Patient dissatisfaction with their daily functioning No other illness Do not take other medications No contraindications to amantadine

Exclusion criteria

Exclusion criteria: Do not exercise regularly Complications of amantadine Hospitalization for any reason death

Design outcomes

Primary

Measure	Time frame
People whose fatigue rate is determined by the Fatigue Severity Scale (9FSS) to a low to moderate to severe level. Timepoint: Amantadine 100mg treatment group twice daily for three months. Method of measurement: Fatigue Severity Scale(FSS-9).;People whose pain rate is determined by the NRS (Numeric Pain Rating Scale) are low, medium, and severe. Timepoint: Yoga Exercise Group 12 weeks 3 sessions per week. Method of measurement: Numeric Pain Rating Scale(NRS).;People whose quality of life is determined by the Multiple Sclerosis Impact Scale (MSIS-29). Timepoint: Acceptance and commitment group therapy group 12 hours a week one hour a week. Method of measurement: Multiple Sclerosis Impact Scale (MSIS-29).	—

Measure

Time frame

People whose fatigue rate is determined by the Fatigue Severity Scale (9FSS) to a low to moderate to severe level. Timepoint: Amantadine 100mg treatment group twice daily for three months. Method of measurement: Fatigue Severity Scale(FSS-9).;People whose pain rate is determined by the NRS (Numeric Pain Rating Scale) are low, medium, and severe. Timepoint: Yoga Exercise Group 12 weeks 3 sessions per week. Method of measurement: Numeric Pain Rating Scale(NRS).;People whose quality of life is determined by the Multiple Sclerosis Impact Scale (MSIS-29). Timepoint: Acceptance and commitment group therapy group 12 hours a week one hour a week. Method of measurement: Multiple Sclerosis Impact Scale (MSIS-29).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRaheleh Rezaeian Langroudi

Islamic Azad University

r.r1351@yahoo.com+98 81 3821 0047

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026